Actinium Pharmaceuticals Stock Analysis
| ATNM Stock | USD 1.87 0.29 18.35% |
Actinium Pharmaceuticals is undervalued with Real Value of 2.58 and Hype Value of 1.83. The main objective of Actinium Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Actinium Pharmaceuticals is worth, separate from its market price. There are two main types of Actinium Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Actinium Pharmaceuticals stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Actinium Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Actinium Stock trading window is adjusted to America/New York timezone.
Actinium |
Actinium Stock Analysis Notes
About 30.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.22. Some equities with similar Price to Book (P/B) outperform the market in the long run. Actinium Pharmaceuticals recorded a loss per share of 1.39. The entity last dividend was issued on the 11th of August 2020. The firm had 1:30 split on the 11th of August 2020. Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant or a type of cellular therapy, and for other adoptive cell therapies. The company was incorporated in 2000 and is based in New York, New York. Actinium Pharmaceuticals operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 32 people. For more info on Actinium Pharmaceuticals please contact MS MBA at 646 677 3870 or go to https://www.actiniumpharma.com.Actinium Pharmaceuticals Investment Alerts
| Actinium Pharmaceuticals is way too risky over 90 days horizon | |
| Actinium Pharmaceuticals may become a speculative penny stock | |
| Actinium Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 81 K. Net Loss for the year was (48.82 M) with profit before overhead, payroll, taxes, and interest of 81 K. | |
| Actinium Pharmaceuticals currently holds about 116.33 M in cash with (47.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.62, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Actinium Pharmaceuticals Upcoming and Recent Events
| 1st of April 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 1st of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Actinium Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 49.29 M.Technical Drivers
As of the 26th of March, Actinium Pharmaceuticals shows the Downside Deviation of 4.41, risk adjusted performance of 0.1207, and Mean Deviation of 4.26. Actinium Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Actinium Pharmaceuticals variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Actinium Pharmaceuticals is priced correctly, providing market reflects its regular price of 1.87 per share. Please also double-check Actinium Pharmaceuticals total risk alpha, which is currently at 0.7752 to validate the company can sustain itself at a future point.Actinium Pharmaceuticals Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Actinium Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Actinium Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Actinium Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Actinium Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Actinium Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Actinium Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Seth Sandesh over three weeks ago Acquisition by Seth Sandesh of 8125 shares of Actinium Pharmaceuticals at 0.6 subject to Rule 16b-3 | ||
Almenoff June Sherie over three months ago Insider Trading | ||
Nicholson, C. David over six months ago Acquisition by Nicholson, C. David of 70311 shares of Actinium Pharmaceuticals at 5.0 subject to Rule 16b-3 | ||
Mark Berger over six months ago Acquisition by Mark Berger of 400000 shares of Actinium Pharmaceuticals at 0.232 subject to Rule 16b-3 | ||
C Nicholson over a year ago Acquisition by C Nicholson of 70311 shares of Actinium Pharmaceuticals subject to Rule 16b-3 |
Actinium Pharmaceuticals Outstanding Bonds
Actinium Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Actinium Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Actinium bonds can be classified according to their maturity, which is the date when Actinium Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| ACTAVIS FDG SCS Corp BondUS00507UAS06 | View | |
| ACTIVISION BLIZZARD INC Corp BondUS00507VAQ23 | View | |
| US00507VAP40 Corp BondUS00507VAP40 | View | |
| ACTIVISION BLIZZARD INC Corp BondUS00507VAM19 | View | |
| ACTIVISION BLIZZARD INC Corp BondUS00507VAK52 | View |
Actinium Pharmaceuticals Predictive Daily Indicators
Actinium Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Actinium Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Actinium Pharmaceuticals Forecast Models
Actinium Pharmaceuticals' time-series forecasting models are one of many Actinium Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Actinium Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Actinium Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Actinium Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Actinium shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Actinium Pharmaceuticals. By using and applying Actinium Stock analysis, traders can create a robust methodology for identifying Actinium entry and exit points for their positions.
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant or a type of cellular therapy, and for other adoptive cell therapies. The company was incorporated in 2000 and is based in New York, New York. Actinium Pharmaceuticals operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 32 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Actinium Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Actinium Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Actinium Stock, please use our How to Invest in Actinium Pharmaceuticals guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Actinium Pharmaceuticals. If investors know Actinium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Actinium Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Actinium Pharmaceuticals is measured differently than its book value, which is the value of Actinium that is recorded on the company's balance sheet. Investors also form their own opinion of Actinium Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Actinium Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Actinium Pharmaceuticals' market value can be influenced by many factors that don't directly affect Actinium Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Actinium Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Actinium Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Actinium Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.